Welcome to See King Alpha's Wall Street breakfast, where we cover the top news for investors every morning.

Good morning. Today is Tuesday, December 26th. I'm Julie Morgan.

AstraZeneca is buying Greysell.

Sir Jim Radcliffe will own a piece of Man U.

And Stratisis gets an offer from Nanodimension.

AstraZeneca announced today Tuesday that it has entered into a definitive agreement

to acquire China-based Grey Cell Technologies for up to $1.2 billion.

Per the terms, the company will acquire the fully diluted share capital of Graysell

through a merger with each share valued at $2.

Additionally, the deal includes an unchangeable contingent value right of up to 30 cents per share in cash,

which will be paid upon the achievement of specific regulatory and sales milestones.

AstraZeneca said in a statement, the upfront cash portion of milestones. closing price for its American depository shares of $6.19 and with the

potential for additional contingent value payments the total worth of the

deal could reach 1.2 billion and It will also acquire the cash, cash equivalents and

short-term investments on Graysell's balance sheet which totaled 234.1

million dollars as of the end of September.

The company said pursuant to the deal, Graysell will operate as a wholly owned subsidiary

of AstraZeneca, with operations in China and the U.S. without impacting AstraZeneca's financial guidance for

2023.

The transaction is expected to close in the first quarter of 2024.

Pre-market Graysell is up 60%.

Famed Soccer Club Manchester United has agreed to sell a 25% stake to British billionaires Sir Jim Radcliffe for 1.3 billion dollars.

...